Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

How dosing of ziprasidone in a state hospital system differs from product labeling.

Citrome L, Jaffe A, Levine J.

J Clin Psychiatry. 2009 Jul;70(7):975-82.

PMID:
19653974
2.

Dosing of quetiapine in schizophrenia: how clinical practice differs from registration studies.

Citrome L, Jaffe A, Levine J, Lindenmayer JP.

J Clin Psychiatry. 2005 Dec;66(12):1512-6. Review.

PMID:
16401150
3.

Variables associated with high olanzapine dosing in a state hospital.

Botts S, Littrell R, de Leon J.

J Clin Psychiatry. 2004 Aug;65(8):1138-43.

PMID:
15323601
4.

An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder.

Goff DC, Posever T, Herz L, Simmons J, Kletti N, Lapierre K, Wilner KD, Law CG, Ko GN.

J Clin Psychopharmacol. 1998 Aug;18(4):296-304.

PMID:
9690695
5.

Methodological concerns in a trial of ziprasidone and olanzapine.

Ross DE.

Am J Psychiatry. 2005 Jul;162(7):1391; author reply 1391-2. No abstract available.

PMID:
15994735
6.

Excessive antipsychotic dosing in 2 U.S. State hospitals.

Diaz FJ, De Leon J.

J Clin Psychiatry. 2002 Nov;63(11):998-1003.

PMID:
12444813
7.

How sequential studies inform drug development: evaluating the effect of food intake on optimal bioavailability of ziprasidone.

Lincoln J, Stewart ME, Preskorn SH.

J Psychiatr Pract. 2010 Mar;16(2):103-14. doi: 10.1097/01.pra.0000369971.64908.dc.

PMID:
20511734
8.

Switching from quetiapine to ziprasidone: a sixteen-week, open-label, multicenter study evaluating the effectiveness and safety of ziprasidone in outpatient subjects with schizophrenia or schizoaffective disorder.

Karayal ON, Glue P, Bachinsky M, Stewart M, Chappell P, Kolluri S, Cavus I.

J Psychiatr Pract. 2011 Mar;17(2):100-9. doi: 10.1097/01.pra.0000396061.05269.c8.

PMID:
21430488
9.

Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.

Potkin SG, Keck PE Jr, Segal S, Ice K, English P.

J Clin Psychopharmacol. 2005 Aug;25(4):301-10.

PMID:
16012271
10.

Focus on ziprasidone.

Green B.

Curr Med Res Opin. 2001;17(2):146-50. Review.

PMID:
11759185
11.

Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients.

Lesem MD, Zajecka JM, Swift RH, Reeves KR, Harrigan EP.

J Clin Psychiatry. 2001 Jan;62(1):12-8. Erratum in: J Clin Psychiatry 2001 Mar;62(3):209.

PMID:
11235922
12.

[Practical aspects of the use of ziprasidone in schizophrenia].

Ochedzan D, Jarema M.

Psychiatr Pol. 2010 Nov-Dec;44(6):881-93. Review. Polish.

PMID:
21449170
13.

Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia.

Stimmel GL, Gutierrez MA, Lee V.

Clin Ther. 2002 Jan;24(1):21-37. Review.

PMID:
11833834
14.

Effects of Oral Ziprasidone and Oral Haloperidol on QTc interval in patients with Schizophrenia or Schizoaffective disorder.

Miceli JJ, Tensfeldt TG, Shiovitz T, Anziano R, O'Gorman C, Harrigan RH.

Pharmacotherapy. 2010 Feb;30(2):127-35. doi: 10.1592/phco.30.2.127.

PMID:
20099987
15.

Real-life switching strategies with second-generation antipsychotics.

Correll CU.

J Clin Psychiatry. 2006 Jan;67(1):160-1. No abstract available.

PMID:
16426102
16.

Risperidone use at a state hospital: a clinical audit 2 years after the first wave of risperidone prescriptions.

Chengappa KN, Sheth S, Brar JS, Parepally H, Marcus S, Gopalani A, Palmer A, Baker RW, Schooler NR.

J Clin Psychiatry. 1999 Jun;60(6):373-8.

PMID:
10401915
17.
18.

Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder.

Miceli JJ, Tensfeldt TG, Shiovitz T, Anziano RJ, O'Gorman C, Harrigan RH.

Clin Ther. 2010 Mar;32(3):472-91. doi: 10.1016/j.clinthera.2010.03.003.

PMID:
20399985
19.

Using oral ziprasidone effectively: the food effect and dose-response.

Citrome L.

Adv Ther. 2009 Aug;26(8):739-48. doi: 10.1007/s12325-009-0055-0. Epub 2009 Aug 8. Review.

PMID:
19669631
20.

Intramuscular ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia.

Barak Y, Mazeh D, Plopski I, Baruch Y.

Am J Geriatr Psychiatry. 2006 Jul;14(7):629-33.

PMID:
16816018
Items per page

Supplemental Content

Write to the Help Desk